Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3844776 | Actas Urológicas Españolas | 2007 | 9 Pages |
Abstract
Experience of some groups in HIFU is highly promising. Local tumour destruction is evident both in primary and relapsed PCa cases. To make conclusions in the long-term, controlled-randomized trials must be designed, with follow-up to measure benefits in global survival and quality of live. Comparisons must be completed with conventional techniques, and a uniform definition of disease free-survival is necessary.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
E. Lledó GarcÃa, J. Jara Rascón, F. Herranz Amo, C. Hernández Fernández,